Home Instead

Item 7 lays out the initial investment range of $91,040 to $269,750, including a $54,000 franchise fee, making entry accessible compared to medical-focused rivals. Ongoing fees hit 5% royalty, 2% ad fund, plus $500 monthly technology and $209-$3,418 systems fees, which can add up in a high-revenue operation. Item 19 shines brightest: average gross revenue clocks $2,609,616 with a median of $2,261,503 across reporting units, suggesting strong top-line potential in the aging population boom, though profitability hinges on local staffing and client density.

System health metrics paint a steady but slow-growth picture—619 franchised locations plus 6 corporate, up just 1% from 616 in 2023 to 620 in 2024, with only 8 projected new units amid 54 transfers. SBA data bolsters confidence: 366 loans averaging $628,073 and a tiny 0.8% default rate, far below industry norms, indicating franchisees can finance and sustain. Litigation clusters around non-renewals and non-competes, a common friction in mature systems, but low defaults imply resilient operations. For investors eyeing recession-proof care services, the revenue scale tempts, yet tepid expansion demands scrutiny of territorial saturation.